
Arbor Biotechnologies names Mathew Pletcher as new Chief Scientific Officer to boost gene editing pipeline.
Arbor Biotechnologies appointed Mathew Pletcher, Ph.D., as its new Chief Scientific Officer, succeeding John Murphy who is retiring. Dr. Pletcher brings nearly 20 years of experience in gene therapy and rare diseases, having held leadership roles at ...
